SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-16-141737
Filing Date
2016-08-29
Accepted
2016-08-29 06:01:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a16-17517_2sc13da.htm SC 13D/A 38277
  Complete submission text file 0001104659-16-141737.txt   39552
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Subject) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87188 | Film No.: 161856024
SIC: 2834 Pharmaceutical Preparations

Mailing Address 330 MADISON AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address
Shkreli Martin (Filed by) CIK: 0001525354 (see all company filings)

Type: SC 13D/A